Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Opinions Are Mixed on These NA Stocks: Corcept Therapeutics (CORT) and Fiserv (FISV)

Tipranks - Tipranks - Tue Mar 24, 7:02AM CDT

Analysts have been eager to weigh in on the NA sector with new ratings on Corcept Therapeutics (CORT) and Fiserv (FISV).

Claim 30% Off TipRanks Premium

Corcept Therapeutics (CORT)

Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics yesterday and set a price target of $100.00. The company’s shares closed last Friday at $34.64.

According to TipRanks.com, Nash is a 5-star analyst with an average return of 23.5% and a 47.6% success rate. Nash covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc. Class A, Madrigal Pharmaceuticals, and Kiniksa Pharmaceuticals. ;'>

Corcept Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $93.67, a 163.9% upside from current levels. In a report issued on March 14, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $36.00 price target.

See the top stocks recommended by analysts >>

Fiserv (FISV)

Wells Fargo analyst Andrew Bauch assigned a Hold rating to Fiserv on March 20 and set a price target of $72.00. The company’s shares closed last Friday at $57.07.

According to TipRanks.com, Bauch is ranked #10561 out of 12128 analysts.

Currently, the analyst consensus on Fiserv is a Hold with an average price target of $75.24, which is a 32.3% upside from current levels. In a report issued on March 11, Cantor Fitzgerald also maintained a Hold rating on the stock with a $70.00 price target.

Read More on CORT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).